GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Piotroski F-Score

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Piotroski F-Score : 7 (As of Apr. 15, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Piotroski F-Score?

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Haoyuan Chemexpress Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Shanghai Haoyuan Chemexpress Co's Piotroski F-Score or its related term are showing as below:

SHSE:688131' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 7
Current: 7

During the past 12 years, the highest Piotroski F-Score of Shanghai Haoyuan Chemexpress Co was 7. The lowest was 1. And the median was 4.


Shanghai Haoyuan Chemexpress Co Piotroski F-Score Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Piotroski F-Score Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 1.00 3.00 7.00

Shanghai Haoyuan Chemexpress Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 4.00 5.00 7.00

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 16.757 + 53.65 + 72.94 + 58.242 = ¥202 Mil.
Cash Flow from Operations was 28.325 + 48.774 + 81.908 + 222.952 = ¥382 Mil.
Revenue was 504.874 + 550.675 + 563.514 + 651.114 = ¥2,270 Mil.
Gross Profit was 205.99 + 272.964 + 291.417 + 318.528 = ¥1,089 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(4192.208 + 4321.443 + 4372.65 + 4683.503 + 5504.946) / 5 = ¥4614.95 Mil.
Total Assets at the begining of this year (Dec23) was ¥4,192 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,247 Mil.
Total Current Assets was ¥3,175 Mil.
Total Current Liabilities was ¥1,260 Mil.
Net Income was 46.236 + 48.62 + 23.309 + 9.284 = ¥127 Mil.

Revenue was 418.365 + 462.553 + 495.196 + 503.933 = ¥1,880 Mil.
Gross Profit was 210.556 + 230.676 + 223.933 + 184.007 = ¥849 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(3597.745 + 3796.597 + 3976.249 + 4120.202 + 4192.208) / 5 = ¥3936.6002 Mil.
Total Assets at the begining of last year (Dec22) was ¥3,598 Mil.
Long-Term Debt & Capital Lease Obligation was ¥398 Mil.
Total Current Assets was ¥2,188 Mil.
Total Current Liabilities was ¥1,164 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Haoyuan Chemexpress Co's current Net Income (TTM) was 202. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Haoyuan Chemexpress Co's current Cash Flow from Operations (TTM) was 382. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=201.589/4192.208
=0.04808659

ROA (Last Year)=Net Income/Total Assets (Dec22)
=127.449/3597.745
=0.03542469

Shanghai Haoyuan Chemexpress Co's return on assets of this year was 0.04808659. Shanghai Haoyuan Chemexpress Co's return on assets of last year was 0.03542469. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai Haoyuan Chemexpress Co's current Net Income (TTM) was 202. Shanghai Haoyuan Chemexpress Co's current Cash Flow from Operations (TTM) was 382. ==> 382 > 202 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=1246.665/4614.95
=0.27013619

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=398.095/3936.6002
=0.1011266

Shanghai Haoyuan Chemexpress Co's gearing of this year was 0.27013619. Shanghai Haoyuan Chemexpress Co's gearing of last year was 0.1011266. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=3174.919/1260.187
=2.51940307

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=2188.266/1163.812
=1.88025729

Shanghai Haoyuan Chemexpress Co's current ratio of this year was 2.51940307. Shanghai Haoyuan Chemexpress Co's current ratio of last year was 1.88025729. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai Haoyuan Chemexpress Co's number of shares in issue this year was 207.541. Shanghai Haoyuan Chemexpress Co's number of shares in issue last year was 202.706. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1088.899/2270.177
=0.47965379

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=849.172/1880.047
=0.45167594

Shanghai Haoyuan Chemexpress Co's gross margin of this year was 0.47965379. Shanghai Haoyuan Chemexpress Co's gross margin of last year was 0.45167594. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=2270.177/4192.208
=0.54152299

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=1880.047/3597.745
=0.52256261

Shanghai Haoyuan Chemexpress Co's asset turnover of this year was 0.54152299. Shanghai Haoyuan Chemexpress Co's asset turnover of last year was 0.52256261. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Haoyuan Chemexpress Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai Haoyuan Chemexpress Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines